New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.
The research, led by Nalinikanth Kotagiri, PhD, was recently…
New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.
The research, led by Nalinikanth Kotagiri, PhD, was recently…